DBV TECHNOLOGIES (EPA:DBV) | WebDisclosure

Basculer en Français

11299	Companies
251105	Keywords
180068	Articles
136946	Press releases

Home
Companies
DBV TECHNOLOGIES

PRESS RELEASE

published on 04/11/2025 at 22:30, 1 year 6 months ago

DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistrement Universel 2024
DBV Technologies publie son "Form 10-K" américain et son Document d'Enregistrement Universel 2024, confirmant la stabilité de ses états financiers et les dépôts auprès de la SEC et de l'AMF

Biopharmaceutique États Financiers Form 10-K DBV Technologies DEU 2024
PRESS RELEASE

published on 04/11/2025 at 22:30, 1 year 6 months ago

DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document
DBV Technologies files 2024 Annual Report on Form 10-K and Universal Registration Document, providing financial updates and corporate governance details

Financial Updates Universal Registration Document Form 10-K DBV Technologies 2024 Annual Report
BRIEF

published on 04/04/2025 at 11:22, 1 year 7 months ago

Franchissement de seuils chez DBV Technologies

Capital Franchissement De Seuil Actions DBV Technologies Syquant Capital
BRIEF

published on 04/04/2025 at 11:22, 1 year 7 months ago

Crossing thresholds at DBV Technologies

Capital Actions Threshold Crossing DBV Technologies Syquant Capital
PRESS RELEASE

published on 04/04/2025 at 11:17, 1 year 7 months ago

Franchissement de seuils
Déclaration de franchissement de seuils de DBV Technologies par Syquant Capital pour le compte de fonds, le 2 avril 2025

Déclaration Actions Franchissement De Seuils DBV Technologies Syquant Capital
PRESS RELEASE

published on 03/28/2025 at 03:30, 1 year 7 months ago

DBV Technologies Annonce un Financement pouvant atteindre 306,9 millions de dollars (284,5 millions d’euros) permettant d’avancer le programme Viaskin® Peanut jusqu’au dépôt d'une Demande de Licence Biologique (BLA) et d’assurer la...
PRESS RELEASE

published on 03/28/2025 at 03:30, 1 year 7 months ago

DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved
DBV Technologies secures financing of up to $306.9 million (€284.5 million) to advance Viaskin Peanut Patch through FDA submission and US commercial launch. Investors include MPM BioImpact, Adage Capital Management, Janus Henderson Investors, and more

Financing Commercial Launch DBV Technologies FDA Submission Viaskin Peanut Patch
BRIEF

published on 03/24/2025 at 07:35, 1 year 7 months ago

DBV Technologies anticipe une avancée réglementaire avec la FDA

DBV Technologies Viaskin Peanut Trésorerie 2024 FDA Accord Étude VITESSE
BRIEF

published on 03/24/2025 at 07:35, 1 year 7 months ago

DBV Technologies Anticipates Regulatory Progress with the FDA

FDA Agreement DBV Technologies Viaskin Peanut Treasury 2024 SPEED Study
PRESS RELEASE

published on 03/24/2025 at 07:30, 1 year 7 months ago

DBV Technologies conclut un accord avec la FDA sur les données d'innocuité requises pour la demande de BLA du patch Viaskin® Peanut chez les enfants de 4-7 ans, accélérant ainsi au premier semestre 2026 le dépôt de la demande…
DBV Technologies conclut un accord avec la FDA sur les données d'innocuité du patch Viaskin Peanut, anticipant un dépôt au 1er semestre 2026, et publie ses résultats financiers 2024

Résultats Financiers FDA DBV Technologies Viaskin Peanut Innocuité

Accesswire

Published on 11/09/2026 at 15:00, 12 minutes ago

Shelfietech Launched New Retail Software Platform
Published on 11/09/2026 at 14:30, 42 minutes ago

Boron One Applies for New Exploration Licence
Published on 11/09/2026 at 14:15, 57 minutes ago

Jericho Energy Ventures to Participate in Cantor Convergence 4th Annual Crypto and AI Infrastructure Conference
Published on 11/09/2026 at 14:00, 1 hour 12 minutes ago

Tectonic Metals Adds Mine Development and Alaska Native Partnership Leaders Ahead of 2027 Mineral Resource Estimate and Preliminary Economic Assessment
Published on 11/09/2026 at 13:35, 1 hour 37 minutes ago

Gabriel Provides Corporate Update

View all ACCESSWIRE

EQS Group

Published on 11/09/2026 at 15:05, 6 minutes ago

DIVEROID's WatchDive Turns Everyday Smartwatches into Dive Computers, Launching on Kickstarter in December
Published on 11/09/2026 at 15:05, 6 minutes ago

Harley-Davidson Selects Horizon Global as Growth Partner
Published on 11/09/2026 at 15:00, 11 minutes ago

PhotonPay Strengthens North American Regulatory Footprint with Canada's RPAA Registration
Published on 11/09/2026 at 14:55, 16 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 11/09/2026 at 14:54, 17 minutes ago

Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.

Les Echos

Published on 11/09/2026 at 14:31, 40 minutes ago

261109 BENETEAU Transactions sur actions propres
Published on 11/09/2026 at 10:32, 4 hours 40 minutes ago

Disclosure of shares outstanding and voting rights - 09.11.2026
Published on 11/09/2026 at 10:32, 4 hours 40 minutes ago

Déclaration nombre d'actions et droits de vote - 09.11.2026
Published on 11/09/2026 at 07:00, 8 hours 12 minutes ago

bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 8 hours 12 minutes ago

BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA

View all LES ECHOS COMFI WIRE